Yves Souteyrand

2.4k total citations · 1 hit paper
28 papers, 1.5k citations indexed

About

Yves Souteyrand is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Yves Souteyrand has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Economics and Econometrics. Recurrent topics in Yves Souteyrand's work include HIV/AIDS Research and Interventions (22 papers), HIV, Drug Use, Sexual Risk (13 papers) and HIV/AIDS Impact and Responses (7 papers). Yves Souteyrand is often cited by papers focused on HIV/AIDS Research and Interventions (22 papers), HIV, Drug Use, Sexual Risk (13 papers) and HIV/AIDS Impact and Responses (7 papers). Yves Souteyrand collaborates with scholars based in Switzerland, United States and South Africa. Yves Souteyrand's co-authors include Marco Vitória, Siobhan Crowley, Teguest Guerma, Charles F. Gilks, Jos Perriëns, René Ekpini, Kevin De Cock, S Gove, Brian Williams and Reuben Granich and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yves Souteyrand

28 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

2006 510 citations Charles F. Gilks, Siobhan Crowley et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yves Souteyrand Switzerland	14	1.0k	434	421	386	352	28	1.5k
Namwinga Chintu Zambia	21	953 0.9×	289 0.7×	364 0.9×	550 1.4×	585 1.7×	44	1.7k
Mark A. Micek United States	24	875 0.8×	218 0.5×	453 1.1×	384 1.0×	629 1.8×	48	1.6k
Fèrnet Leandre United States	15	803 0.8×	192 0.4×	345 0.8×	290 0.8×	442 1.3×	26	1.3k
Charles Kilewo Tanzania	19	908 0.9×	247 0.6×	510 1.2×	416 1.1×	591 1.7×	46	1.4k
Alwyn Mwinga Zambia	16	1.1k 1.1×	355 0.8×	630 1.5×	218 0.6×	279 0.8×	33	1.6k
Erik J Schouten Malawi	29	1.8k 1.7×	366 0.8×	789 1.9×	856 2.2×	959 2.7×	65	2.5k
Simon D Makombe Malawi	23	1.7k 1.6×	539 1.2×	976 2.3×	392 1.0×	611 1.7×	41	2.0k
Jan A. C. Hontelez Netherlands	21	948 0.9×	208 0.5×	690 1.6×	199 0.5×	394 1.1×	55	1.4k
Nancy Scott United States	18	603 0.6×	168 0.4×	370 0.9×	535 1.4×	378 1.1×	68	1.4k
Katherine Hilderbrand South Africa	20	1.5k 1.4×	480 1.1×	701 1.7×	307 0.8×	443 1.3×	32	1.7k

Countries citing papers authored by Yves Souteyrand

Since Specialization

Citations

This map shows the geographic impact of Yves Souteyrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Souteyrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Souteyrand more than expected).

Fields of papers citing papers by Yves Souteyrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Souteyrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Souteyrand. The network helps show where Yves Souteyrand may publish in the future.

Co-authorship network of co-authors of Yves Souteyrand

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Souteyrand. A scholar is included among the top collaborators of Yves Souteyrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Souteyrand. Yves Souteyrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Safer, Mouna, et al.. (2023). Baseline Seroprevalence of SARS-CoV-2 Specific Antibodies in Hot Spot Areas of Great Tunis, up to 3 Months Post Disease Onset in Tunisia. SHILAP Revista de lepidopterología. 4(2). 188–201. 1 indexed citations

Bouey, Paul D., Siân Curtis, Mindy Hochgesang, et al.. (2012). Beyond Indicators. JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(Supplement 3). S120–S126. 20 indexed citations

Granich, Reuben, Ying-Ru Lo, Amitabh B. Suthar, et al.. (2011). Harnessing the Prevention Benefits of Antiretroviral Therapy to Address HIV and Tuberculosis. Current HIV Research. 9(6). 355–366. 5 indexed citations

Tassie, Jean-Michel, Silvia Bertagnolio, & Yves Souteyrand. (2011). Integrated surveillance of HIV care in low-income and middle-income countries. Current Opinion in HIV and AIDS. 6(4). 233–238. 5 indexed citations

Granich, Reuben, Siobhan Crowley, Marco Vitória, et al.. (2010). Highly active antiretroviral treatment for the prevention of HIV transmission. Journal of the International AIDS Society. 13(1). 1–1. 93 indexed citations

Stanecki, Karen A, et al.. (2010). Antiretroviral therapy needs: the effect of changing global guidelines. Sexually Transmitted Infections. 86(Suppl 2). ii62–ii66. 9 indexed citations

Tassie, Jean-Michel, et al.. (2010). Trends in Retention on Antiretroviral Therapy in National Programs in Low-Income and Middle-Income Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(4). 437–441. 45 indexed citations

Tassie, Jean-Michel, Karen Malateste, Mar Pujades‐Rodríguez, et al.. (2010). Evaluation of Three Sampling Methods to Monitor Outcomes of Antiretroviral Treatment Programmes in Low- and Middle-Income Countries. PLoS ONE. 5(11). e13899–e13899. 11 indexed citations

Mahy, Mary, Charlotte Lewden, Martin W. G. Brinkhof, et al.. (2010). Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy. Sexually Transmitted Infections. 86(Suppl 2). ii28–ii34. 26 indexed citations

10.

Granich, Reuben, Siobhan Crowley, Marco Vitória, et al.. (2010). Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Current Opinion in HIV and AIDS. 5(4). 298–304. 132 indexed citations

11.

Hamilton, Amy L., Jesus Maria Garcia Calleja, Marco Vitória, et al.. (2010). Changes in antiretroviral therapy guidelines: implications for public health policy and public purses. Sexually Transmitted Infections. 86(5). 388–390. 2 indexed citations

12.

Mahy, Mary, Jean-Michel Tassie, Peter D. Ghys, et al.. (2009). Estimation of antiretroviral therapy coverage: methodology and trends. Current Opinion in HIV and AIDS. 5(1). 97–102. 18 indexed citations

13.

Souteyrand, Yves, et al.. (2008). Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries. AIDS. 22(Suppl 1). S161–S168. 49 indexed citations

14.

Souteyrand, Yves, et al.. (2008). Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?. Globalization and Health. 4(1). 8–8. 133 indexed citations

15.

Beck, Eduard J., Marco Vitória, Sundhiya Mandalia, et al.. (2006). National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?. AIDS. 20(11). 1497–1502. 49 indexed citations

16.

James, Chris, Kara Hanson, Barbara McPake, et al.. (2006). To Retain or Remove User Fees?. Applied Health Economics and Health Policy. 5(3). 137–153. 196 indexed citations

17.

Gilks, Charles F., Siobhan Crowley, René Ekpini, et al.. (2006). The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. The Lancet. 368(9534). 505–510. 510 indexed citations breakdown →

18.

Moatti, Jean‐Paul, et al.. (2003). Financing efficient HIV care and antiretroviral treatment to mitigate the impact of the AIDS epidemic on economic and human development. RePEc: Research Papers in Economics. 247–265. 2 indexed citations

19.

Souteyrand, Yves. (1993). Impact économique du HIV.. 61. 29–33. 1 indexed citations

20.

Tursz, Anne, Yves Souteyrand, & Louis‐Rachid Salmi. (1993). Adolescence et risque. Medical Entomology and Zoology. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact